Search Results

NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number alterations (CNAs), recently published research demonstrating capabilities of their blocker displacement amplification (BDA) technology for detection of a JAK2 mutation using qPCR.

Bio-Rad Laboratories, Inc., (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, today announced the signing of a licensing and product development agreement.

NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, and Bionano Genomics, based in San Diego, California, have entered into a procurement and collaboration agreement.

NuProbe scientists and collaborators recently announced research demonstrating the accurate quantitation of somatic mutations below 0.01% variant allele frequency (VAF).

NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, announces the closing of its oversubscribed $42M fundraising. The lead investors for this financing round are BioTrack Capital and Yonghua Capital.

NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, launches its VarMapTM Pan-Cancer NGS Panel.

NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive oncology assays, announced research on DNA microsatellites published today in Nucleic Acids Research. Simultaneously, the company announced the release of the VarTrace® MSI qPCR research use only assay for detection of DNA microsatellite instability (MSI) from tissue or blood specimens.

NuProbe, an innovator of genomics and molecular diagnostics technologies, announces the launch of the Augury™ platform for automated design of customized liquid biopsy NGS panels.

NUPROBE GLOBAL, a molecular diagnostics company based in Shanghai, China and Houston, Texas, has reached a strategic collaboration agreement with AcornMed Biotechnology Co., Ltd.

NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing assays, announced research demonstrating the ability to detect single nucleotide variants (SNVs) in DNA with a variant allele frequency (VAF) of ≤0.02% using a sequencing depth of only 250x.